BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26479144)

  • 41. Effects of adaptive servo-ventilation therapy on cardiac function and remodeling in patients with chronic heart failure (SAVIOR-C): study protocol for a randomized controlled trial.
    Seino Y; Momomura S; Kihara Y; Adachi H; Yasumura Y; Yokoyama H;
    Trials; 2015 Jan; 16():14. PubMed ID: 25928620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.
    Natsumeda M; Florea V; Rieger AC; Tompkins BA; Banerjee MN; Golpanian S; Fritsch J; Landin AM; Kashikar ND; Karantalis V; Loescher VY; Hatzistergos KE; Bagno L; Sanina C; Mushtaq M; Rodriguez J; Rosado M; Wolf A; Collon K; Vincent L; Kanelidis AJ; Schulman IH; Mitrani R; Heldman AW; Balkan W; Hare JM
    J Am Coll Cardiol; 2017 Nov; 70(20):2504-2515. PubMed ID: 29145950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
    Uccelli A; Laroni A; Brundin L; Clanet M; Fernandez O; Nabavi SM; Muraro PA; Oliveri RS; Radue EW; Sellner J; Soelberg Sorensen P; Sormani MP; Wuerfel JT; Battaglia MA; Freedman MS;
    Trials; 2019 May; 20(1):263. PubMed ID: 31072380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.
    Laksman Z; Yee R; Stirrat J; Gula LJ; Skanes AC; Leong-Sit P; Manlucu J; McCarty D; Turkistani Y; Scholl D; Rajchl M; Goela A; Islam A; Thompson RT; Drangova M; White JA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1040-7. PubMed ID: 25221334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.
    Patel AN; Henry TD; Quyyumi AA; Schaer GL; Anderson RD; Toma C; East C; Remmers AE; Goodrich J; Desai AS; Recker D; DeMaria A;
    Lancet; 2016 Jun; 387(10036):2412-21. PubMed ID: 27059887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of cardiac MRI in nonischemic cardiomyopathies.
    Anand S; Janardhanan R
    Indian Heart J; 2016; 68(3):405-9. PubMed ID: 27316506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intramyocardial angiogenic cell precursor injection for cardiomyopathy.
    Arom KV; Ruengsakulrach P; Jotisakulratana V
    Asian Cardiovasc Thorac Ann; 2008 Apr; 16(2):143-8. PubMed ID: 18381874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial.
    Attar A; Farjoud Kouhanjani M; Hessami K; Vosough M; Kojuri J; Ramzi M; Hosseini SA; Faghih M; Monabati A
    Stem Cell Res Ther; 2023 Sep; 14(1):264. PubMed ID: 37740221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.
    Sola S; Mir MQ; Lerakis S; Tandon N; Khan BV
    J Am Coll Cardiol; 2006 Jan; 47(2):332-7. PubMed ID: 16412856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis of cell therapy trials for patients with heart failure.
    Fisher SA; Doree C; Mathur A; Martin-Rendon E
    Circ Res; 2015 Apr; 116(8):1361-77. PubMed ID: 25632038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.
    Piers SR; Tao Q; de Riva Silva M; Siebelink HM; Schalij MJ; van der Geest RJ; Zeppenfeld K
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):774-84. PubMed ID: 25051947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).
    Mathiasen AB; Qayyum AA; Jørgensen E; Helqvist S; Fischer-Nielsen A; Kofoed KF; Haack-Sørensen M; Ekblond A; Kastrup J
    Eur Heart J; 2015 Jul; 36(27):1744-53. PubMed ID: 25926562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial.
    St John Sutton M; Plappert T; Adamson PB; Li P; Christman SA; Chung ES; Curtis AB
    Circ Heart Fail; 2015 May; 8(3):510-8. PubMed ID: 25697851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of time course of response to cardiac resynchronization therapy in patients with ischemic versus nonischemic cardiomyopathy.
    Marsan NA; Bleeker GB; van Bommel RJ; Ypenburg C; Delgado V; Borleffs CJ; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2009 Mar; 103(5):690-4. PubMed ID: 19231335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic Accuracy of Cardiac Magnetic Resonance Imaging in the Evaluation of Newly Diagnosed Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Won E; Donnino R; Srichai MB; Sedlis SP; Feit F; Rolnitzky L; Miller LH; Iqbal SN; Axel L; Nguyen B; Slater J; Shah B
    Am J Cardiol; 2015 Oct; 116(7):1082-7. PubMed ID: 26251006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure.
    Patel AN; Mittal S; Turan G; Winters AA; Henry TD; Ince H; Trehan N
    Stem Cells Transl Med; 2015 Sep; 4(9):1021-7. PubMed ID: 26217065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.
    Grønhøj C; Jensen DH; Glovinski PV; Jensen SB; Bardow A; Oliveri RS; Specht L; Thomsen C; Darkner S; Kiss K; Fischer-Nielsen A; von Buchwald C
    Trials; 2017 Mar; 18(1):108. PubMed ID: 28270226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic manipulation in chronic heart failure: study protocol for a randomised controlled trial.
    Beadle RM; Williams LK; Abozguia K; Patel K; Leon FL; Yousef Z; Wagenmakers A; Frenneaux MP
    Trials; 2011 Jun; 12():140. PubMed ID: 21645332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The ixCELL-DCM Trial: Rationale and Design.
    Henry TD; Schaer GL; DeMaria A; Recker D; Remmers AE; Goodrich J; Patel AN
    Cell Transplant; 2016; 25(9):1689-1699. PubMed ID: 27009022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.